Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Opioid REMS: Moving Forward, Safely and Effectively Complimentary CME Online Module
  • USA - English

Purdue University College of Pharmacy is pleased to offer an online initiative on Opioid REMS. "Opioid REMS: Moving Forward, Safely and Effectively" is designed for physicians and other healthcare providers who are registered prescribers of controlled substances with the United States Drug Enforcement Administration - including physicians, nurse practitioners (NPs), physician assistants (PAs), and, in some states, pharmacists. In addition, non-prescribing healthcare team members who support the treatment and management of patients with pain but are not authorized to prescribe, such as pharmacists and nurses, will benefit from participating in this educational series.


News provided by

Purdue University College of Pharmacy

Jan 25, 2022, 03:00 ET

Share this article

Share toX

Share this article

Share toX

AUSTIN, Texas, Jan. 25, 2022 /PRNewswire-PRWeb/ -- Purdue University College of Pharmacy is pleased to offer an online initiative on Opioid REMS. "Opioid REMS: Moving Forward, Safely and Effectively" is designed for physicians and other healthcare providers who are registered prescribers of controlled substances with the United States Drug Enforcement Administration – including physicians, nurse practitioners (NPs), physician assistants (PAs), and, in some states, pharmacists. In addition, non-prescribing healthcare team members who support the treatment and management of patients with pain but are not authorized to prescribe, such as pharmacists and nurses, will benefit from participating in this educational series.

Managing patients with chronic and acute pain can be a challenge but is even more so in today's climate. When managing these patients, clinicians need to know how their clinical practice compares to the experts. Opioid REMS: Moving Forward, Safely and Effectively has been developed to provide clinicians with the needed education in the hopes of stemming the tide of the current opioid crisis. In a series of 6 continuing medical education (CME) activities, Dr. Charles Vega will lead discussions that utilize augmented reality to provide critical information and tools that clinicians can integrate into their daily practice – immediately impacting their patients with chronic and acute pain. Dr. Vega is a Clinical Professor, Family Medicine at the University of California, Irvine School of Medicine.

The goals of this CME initiative are to:

1. Reduce the adverse outcomes of addiction, unintentional overdoses, and death resulting from inappropriate prescribing, abuse, and misuse of opioids.

2. Improve the knowledge and competence of healthcare providers treating patients with pain, both chronic and acute, when identifying the options for effectively providing treatment to these patients.

3. Create a personalized learning experience utilizing a dynamic mix of reality-based, moderated, clinical discussions regarding specific patient case examples. A personalized spacing and retention strategy built upon a microlearning design, will also support learners' engagement with the content over time.

This online education activity also features top doctors in the US, including Mohammed Issa, MD, Edgar Ross, MD, with Brigham and Women's Faulkner Hospital and Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNA, who is one of America's Top NP Award Winner, Point of Care Network.

Upon successful completion of the CME activity, participants will be able to:

1. Discuss the basic elements of pain management, including the mechanisms of action of pain.

2. Employ appropriate screening tools to effectively assess patients with pain, including identifying those with potential risk factors that could lead to abuse and addiction.

3. Create effective, individualized treatment plans for patients with acute and chronic pain, while integrating opioid analgesics as necessary to address the needs of the patient.

4. Employ a variety of therapeutic options in the development of effective treatment plans, including the use of non-opioid pharmacology and non-pharmacological approaches.

5. Manage ongoing therapy for patients with pain and modify treatment regimens as needed to achieve adequate pain relief.

6. Monitor and modify pain treatment plans, including the need to discontinue opioid analgesics in a safe and effective manner.

7. Utilize best practices in counseling patients with pain, and their caregivers, about safe and effective use of opioid analgesic therapies, including treatment of opioid overdose.

8. Apply the fundamental elements of addiction medicine to effectively identify and manage patients with opioid use disorder.

To participate in the CME activity, please visit http://www.opioidcme.com.

About Purdue University College of Pharmacy

Purdue University College of Pharmacy Office of Continuing Education promotes the enrichment of an interprofessional and collaborative approach to CE and professional development. Purdue is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians and by the Accreditation Council for Pharmacy Education (ACPE) to provide continuing pharmacy education for pharmacists. Purdue University School of Nursing is accredited by the American Nurses Credentialing Center (ANCC) to provide continuing professional development for nurses.

Release Issued by Audience Generation, LLC

Audience Generation is a forward-thinking agency at the forefront of the digital revolution and is a nationally and internationally recognized provider of integrated marketing, advertising, and technology services and solutions that offer a new way to find, generate, and engage live, online, social, and mobile audiences where they exist on demand.

Audience Generation is known for its creative strategy, actionable solutions, and measurable approach to transforming the ways brands interact with their target audience, whether they exist in person, online, via social networks, or on their mobile devices.

Audience Generation has produced winning traditional, online, e-commerce, social, and mobile campaigns, including mobile application solutions for Fortune 500, small and medium businesses, not-for-profit organizations, national and international associations and societies, and venture-backed start-up companies across a variety of industry verticals around the world.

To learn how Audience Generation can find your ideal customer, reach them where they exist, build your brand, and grow your bottom line, please call us at 512-708-4678 or email us at [email protected] or visit us at http://www.audiencegeneration.com.

Media Contact

Marilyn Morrow, Audience Generation, +1 5127084678, [email protected]

SOURCE Purdue University College of Pharmacy

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.